Chang Shu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chang Shu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Roozbeh Houshyar
University of California, Irvine, Computational Abdominal Radiology Lab - 1001 Health Sciences Rd, Irvine, CA 92617, USA
2 shared publications- Adam Fang
Division of Vascular and Interventional Radiology, Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, Maryland
1 shared publication Alexander Lam
The UCSF Department of Radiology and Biomedical Imaging - 505 Parnassus Avenue, M-391, San Francisco, CA 94143
1 shared publication- Ali Sasani
Department of Radiological Sciences, University of California, Irvine, Orange, CA 92868-3201 (D.S., M.P., S.A., A.S., D.F., R.H.).
1 shared publication Diem My Hoang
Johnston Memorial Hospital, 16000 Johnston Mem Dr, Abingdon, VA 24211, USA
1 shared publication- Diem My Hoang
Johnston Memorial Hospital - 16000 Johnston Mem Dr, Abingdon, VA 24211, USA
1 shared publication
Latest Publications
- 10 July 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (10) , 108958
Ultrasound-Guided Radiofrequency Ablation for a Recurrent Post-Surgical Neck Neuroma: A Case Report
- 10 July 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (10) , 108958
Ultrasound-Guided Radiofrequency Ablation for a Recurrent Post-Surgical Neck Neuroma: A Case Report
- Open Access
- 7 May 2026
- Published by Elsevier in Radiology Case Reports
- Vol. 21 (8) , 3035-3038
Renal angiomyolipoma with inferior vena cava tumor thrombus in a pregnant woman
- 7 May 2026
- Published by Elsevier in Radiology Case Reports
- Vol. 21 (8) , 3035-3038
Open AccessRenal angiomyolipoma with inferior vena cava tumor thrombus in a pregnant woman
- Open Access
- 26 April 2025
- Published by Elsevier in Radiology Case Reports
- Vol. 20 (7) , 3403-3408
Urothelial carcinoma mimicking Bosniak IV cystic mass: A case report
- 26 April 2025
- Published by Elsevier in Radiology Case Reports
- Vol. 20 (7) , 3403-3408
Open AccessUrothelial carcinoma mimicking Bosniak IV cystic mass: A case report
- Open Access
- 7 January 2025
- Published by Elsevier in Radiology Case Reports
- Vol. 20 (3) , 1726-1735
Role of imaging in the diagnosis and management of mixed epithelial and stromal tumors of the kidney: Case series and comprehensive review
- 7 January 2025
- Published by Elsevier in Radiology Case Reports
- Vol. 20 (3) , 1726-1735
Open AccessRole of imaging in the diagnosis and management of mixed epithelial and stromal tumors of the kidney: Case series and comprehensive review
- Open Access
Transarterial Embolization and Percutaneous Ablation of Primary and Metastatic Soft Tissue Tumors
Soft tissue tumors (STTs) include a range of benign and malignant tumors originating from soft tissues. Transarterial and percutaneous therapies are image-guided and minimally invasive approaches for managing primary and metastatic STTs. The objective of this review is to discuss transarterial and percutaneous therapies by examining the current literature, including indications, patient selection, safety, and effectiveness. Transarterial therapies (e.g., transarterial bland embolization and transarterial chemoembolization) involve the delivery of either embolic or chemotherapeutic particles using a catheter into arteries feeding the tumor, resulting in localized tumor destruction. Percutaneous therapies (e.g., radiofrequency ablation, cryoablation, irreversible electroporation, laser ablation, and magnetic resonance-guided high-intensity focused ultrasound) involve the delivery of either hot or cold temperatures, electrical current, laser, or ultrasound to specifically target tumor cells. Both therapies have been shown to be safe and effective for reducing morbidity and local control of STTs, specifically in patients who are surgically inoperable or who are unresponsive to conventional therapies. Accurate diagnosis, staging, and histological subtype identification are crucial for treatment selection. A multidisciplinary approach, a thorough understanding of tissue anatomy and surrounding structures, as well as individualized strategies based on assessment are essential for optimal patient care.
Open AccessTransarterial Embolization and Percutaneous Ablation of Primary and Metastatic Soft Tissue Tumors
Soft tissue tumors (STTs) include a range of benign and malignant tumors originating from soft tissues. Transarterial and percutaneous therapies are image-guided and minimally invasive approaches for managing primary and metastatic STTs. The objective of this review is to discuss transarterial and percutaneous therapies by examining the current literature, including indications, patient selection, safety, and effectiveness. Transarterial therapies (e.g., transarterial bland embolization and transarterial chemoembolization) involve the delivery of either embolic or chemotherapeutic particles using a catheter into arteries feeding the tumor, resulting in localized tumor destruction. Percutaneous therapies (e.g., radiofrequency ablation, cryoablation, irreversible electroporation, laser ablation, and magnetic resonance-guided high-intensity focused ultrasound) involve the delivery of either hot or cold temperatures, electrical current, laser, or ultrasound to specifically target tumor cells. Both therapies have been shown to be safe and effective for reducing morbidity and local control of STTs, specifically in patients who are surgically inoperable or who are unresponsive to conventional therapies. Accurate diagnosis, staging, and histological subtype identification are crucial for treatment selection. A multidisciplinary approach, a thorough understanding of tissue anatomy and surrounding structures, as well as individualized strategies based on assessment are essential for optimal patient care.